wire - kurze nachrichten

MedUni Vienna and University Hospital Vienna are making a visible statement in protest against violence against women and girls once again in 2022 and are participating in UN Women's global "Orange the World" campaign.

A unanimous decision in the Vienna City Council today paved the way for the new Eric Kandel Institute - Center for Precision Medicine to be built.

In mid-November, MedUni Vienna and the University of Vienna appointed Tilman Kühn to the dual professorial chair in Public Health Nutrition (§98).

Thomas Vogl, research group leader at MedUni Vienna's Center for Cancer Research, has received a "Starting Grant" from the European Research Council (ERC) with funding of €1.65 million for five years.

Julia Walochnik, research group leader at the Institute of Specific Prophylaxis and Tropical Medicine at MedUni Vienna's Center for Pathophysiology, Infectiology and Immunology, took up a professorship (§99 (4)) in infectiology at the beginning of November.

MedUni Vienna's Institute of Pathophysiology and Allergy Research has been named a Centre of Excellence for Quantitative Digital Microscopy.

The ALLPreT project, an international research consortium to develop new approaches, tools, and assays that enable the safe introduction of novel foods, has now kicked off.

As of the winter semester of 2022/23, up to ten people can be recruited each year to the Austrian Armed Forces as military doctors via a special 20-year contract.

Cardiovascular disease is the most frequent cause of death in Austria. It includes diseases of the coronary vessels (with heart attack as the worst manifestation), diseases of the heart valves and of arrhythmias.

With the increasing number of cancer survivors, the medical community is becoming increasingly aware of a hitherto less noticed health risk: cancer therapy-related cardiovascular disease.

Pia Gattinger from MedUni Vienna's Center for Pathophysiology, Infectiology and Immunology has received the Life Science Research Award in the "Applied Research" category from the Austrian Society for Molecular Biosciences and Biotechnology (ÖGMBT).

One of Austria's largest medical training centres, the University Simulation Center Vienna, opened its doors about a year ago.

The COVID-19 pandemic has led to changes in clinical routines throughout the world, including the preparation of children for anaesthesia.

Within the framework of the EU Horizon 2020 project "TTV GUIDE TX", MedUni Vienna was the first academic institution in Austria to submit a clinical trial to the Clinical Trials Information System (CTIS) under Europe's new harmonised Clinical Trials Regulation (Regulation (EU) 536/2014).

MedUni Vienna is coordinating an international research project to optimise the use of disease modifying antirheumatic drugs (DMARDs) for treating rheumatoid arthritis. The SQUEEZE project (Maximising Impact of Prescription Drugs in Rheumatoid Arthritis), with total funding of €10.2 million from the EU Framework Programme for Research and Innovation, includes 13 European consortium partners.

Breast, ovarian and uterine cancers account for about 40% of cancer diagnoses in women every year.

Andrea Hochegger, an analytical chemist at TU Graz, investigates whether foodstuffs can be tainted with harmful substances from packaging or during production.

By Susanne Filzwieser In two pilot classes of a Graz school, TU Graz shows that effective ventilation systems in schools and kindergartens can be installed very easily and inexpensively with material from the hardware store.

Vera Vorstandlechner from the Department of Plastic, Reconstructive and Aesthetic Surgery of MedUni Vienna received the award for her research, which focuses on the genetic landscape of hypertrophic scars and the identification of new therapeutic approaches. The study that impressed the expert jury was published in Nature Communications in October 2021 under the title "The serine proteases dipeptidyl-peptidase 4 and urokinase are key molecules in human and mouse scar formation" (https://doi.org/10.1038/s41467'021 -26495-2).

Out of 15,788 applicants who had originally registered, a total of 11,643 candidates took part in today's (Friday's) MedAT joint entrance exam for a place at the medical universities of Vienna, Innsbruck and Graz or the Medical Faculty of Johannes Kepler University in Linz.

The Austrian Neonatal Screening Programme (ÖNGS) has been an ongoing success story since the 1960s.